Implanet Past Earnings Performance

Past criteria checks 0/6

Implanet's earnings have been declining at an average annual rate of -0.9%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 4.5% per year.

Key information

-0.9%

Earnings growth rate

67.5%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate4.5%
Return on equityn/a
Net Margin-89.6%
Next Earnings Update10 Sep 2024

Recent past performance updates

Recent updates

Implanet (EPA:ALIMP) Is Carrying A Fair Bit Of Debt

Mar 21
Implanet (EPA:ALIMP) Is Carrying A Fair Bit Of Debt

Revenue & Expenses Breakdown
Beta

How Implanet makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALIMP Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 237-781
30 Sep 238-571
30 Jun 238-471
31 Mar 238-471
31 Dec 228-471
30 Sep 228-471
30 Jun 228-581
31 Mar 227-571
31 Dec 216-561
30 Sep 217-370
30 Jun 214-351
31 Mar 214-351
31 Dec 204-451
30 Sep 206-461
30 Jun 206-461
31 Mar 207-460
31 Dec 197-470
30 Sep 197-470
30 Jun 197-570
31 Mar 197-571
31 Dec 187-671
30 Sep 187-681
30 Jun 187-681
31 Mar 188-681
31 Dec 178-781
30 Sep 178-781
30 Jun 178-791
31 Mar 178-791
31 Dec 168-791
30 Sep 168-791
30 Jun 167-891
31 Mar 167-881
31 Dec 157-881
30 Sep 156-881
30 Jun 156-881
31 Mar 157-781
31 Dec 147-781
30 Sep 147-771
30 Jun 147-871
31 Mar 147-761
31 Dec 137-761
30 Sep 137-661
30 Jun 137-561

Quality Earnings: ALIMP is currently unprofitable.

Growing Profit Margin: ALIMP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALIMP is unprofitable, and losses have increased over the past 5 years at a rate of 0.9% per year.

Accelerating Growth: Unable to compare ALIMP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALIMP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).


Return on Equity

High ROE: ALIMP's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.